Skip to content
HB

Updated:

Heat Biologics

Heat Biologics is a biotech firm based in Chapel Hill, United States, established in 2008. Scorpius Holdings Inc. operates Scorpius BioManufacturing as a...

Overview

Heat Biologics is a biotech firm based in Chapel Hill, United States, established in 2008. Scorpius Holdings Inc. operates Scorpius BioManufacturing as a contract development and manufacturing organization (CDMO). The firm has secured $81.5 million in total funding.

General information

Firm type

Clinical-stage biopharmaceutical / Immunotherapy developer

Year founded

2008

Location

Region

North America

Country

United States

City

Morrisville

Corporate office

Morrisville, NC, United States

Frequently asked questions

Who runs investment decisions at Heat Biologics?

Public records do not identify a named CEO, CIO, or family principal in charge of investment decisions. The firm has not disclosed its leadership team or governance structure. This lack of transparency makes it difficult to evaluate decision-making authority.

How does Heat Biologics source proprietary deal flow?

The firm does not appear to source external investments. Its focus is entirely internal, developing its ImPACT immunotherapy platform. Without public filings or press releases, no mechanism for deal flow can be confirmed.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles